Stock Detail
KENDLE INTERNATIONAL INC
Drug Manufacturers Other
KNDL @ Yahoo Finance | KNDL Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $9.34 | $9.35 | $0.06 | 0.65% | 0.00 | $9.28 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $9.31 | $9.21 | 61,127 | 139.32M | 135,910.5 | -30.13 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 9.44 | 9.39 | 9.30 | 9.25 | 9.16 |
Stock Profile
Kendle International Inc., a contract research organization, provides integrated clinical research services worldwide. The company's services comprise clinical trial management, clinical data management, statistical analysis, medical writing, regulatory consultation, and organizational meeting management and publication services on a contract basis to the pharmaceutical and biotechnology industries. It performs drug development process through various information technology platforms, such as proprietary TrialWare software, including TrialWeb. The company provides contract services related to Phase I through IV clinical trials. It primarily operates in North America, Latin America, Europe, Asia, Africa, and Australia. Kendle International was founded by Candace Kendle and Chris Bergen in 1981, and is headquartered in Cincinnati, Ohio.